标题
A perspective on SARS-CoV-2 virus-like particles vaccines
作者
关键词
-
出版物
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 115, Issue -, Pages 109650
出版商
Elsevier BV
发表日期
2023-01-11
DOI
10.1016/j.intimp.2022.109650
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination
- (2022) Katharina Röltgen et al. CELL
- Virus-like Particles: Measures and Biological Functions
- (2022) Tara Bhat et al. Viruses-Basel
- Construction of SARS-CoV-2 virus-like particles in plant
- (2022) Ki-Beom Moon et al. Scientific Reports
- Mannose-binding lectin and complement mediate follicular localization and enhanced immunogenicity of diverse protein nanoparticle immunogens
- (2022) Benjamin J. Read et al. Cell Reports
- A Review of Virus-Like Particle-Based SARS-CoV-2 Vaccines in Clinical Trial Phases
- (2022) Mohammad Sharifzadeh et al. Iranian Journal of Pharmaceutical Research
- Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine
- (2022) Karen J. Hager et al. NEW ENGLAND JOURNAL OF MEDICINE
- Broad neutralization against SARS-CoV-2 variants induced by ancestral and B.1.351 AS03-Adjuvanted recombinant Plant-Derived Virus-Like particle vaccines
- (2022) Charlotte Dubé et al. VACCINE
- Safety and immunogenicity of NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults: Interim report of a phase I/II randomized controlled trial
- (2022) Taisei Masuda et al. VACCINE
- Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion
- (2022) Wenlin Ren et al. mBio
- A Capsid Virus-Like Particle-Based SARS-CoV-2 Vaccine Induces High Levels of Antibodies and Protects Rhesus Macaques
- (2022) Ariane Volkmann et al. Frontiers in Immunology
- Development of virus‐like particles‐based vaccines against coronaviruses
- (2022) Chean Yeah Yong et al. BIOTECHNOLOGY PROGRESS
- Self-assembling protein nanoparticles and virus like particles correctly display β-barrel from meningococcal factor H-binding protein through genetic fusion
- (2022) Luigia Cappelli et al. PLoS One
- A Putative long-range RNA-RNA interaction between ORF8 and Spike of SARS-CoV-2
- (2022) Okiemute Beatrice Omoru et al. PLoS One
- A stable platform for the production of virus-like particles pseudotyped with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein
- (2021) Roy Sylvie et al. VIRUS RESEARCH
- Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity
- (2021) Cyrielle Fougeroux et al. Nature Communications
- Modular vaccine platform based on the norovirus-like particle
- (2021) Vili Lampinen et al. JOURNAL OF NANOBIOTECHNOLOGY
- Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021
- (2021) Summer E. Galloway et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine induced sera
- (2021) Daming Zhou et al. CELL
- Emergence of a SARS-CoV-2 variant of concern with mutations in spike glycoprotein
- (2021) Houriiyah Tegally et al. NATURE
- Influence of a COVID-19 vaccine’s effectiveness and safety profile on vaccination acceptance
- (2021) Robert M. Kaplan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers
- (2021) Saghi Nooraei et al. JOURNAL OF NANOBIOTECHNOLOGY
- SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
- (2021) Markus Hoffmann et al. CELL
- Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021
- (2021) Tjede Funk et al. Eurosurveillance
- An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages
- (2021) Hamid Motamedi et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity
- (2021) Muthukumar Ramanathan et al. LANCET INFECTIOUS DISEASES
- Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19
- (2021) Brian J. Ward et al. NATURE MEDICINE
- The impact of spike mutated variants of SARS-CoV2 [Alpha, Beta, Gamma, Delta, and Lambda] on the efficacy of subunit recombinant vaccines
- (2021) Mehrdad Mohammadi et al. Brazilian Journal of Infectious Diseases
- Discovery and evaluation of entry inhibitors for SARS-CoV-2 and its emerging variants
- (2021) Arpan Acharya et al. JOURNAL OF VIROLOGY
- SARS-CoV-2 variants of concern are emerging in India
- (2021) Jasdeep Singh et al. NATURE MEDICINE
- SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern
- (2021) Matthew McCallum et al. SCIENCE
- Overview of SARS-CoV-2 genome-encoded proteins
- (2021) Chongzhi Bai et al. Science China-Life Sciences
- The Spike of SARS-CoV-2: Uniqueness and Applications
- (2021) Ranjith Kumavath et al. Frontiers in Immunology
- Rapid Increase of SARS-CoV-2 Variant B.1.1.7 Detected in Sewage Samples from England between October 2020 and January 2021
- (2021) Thomas Wilton et al. mSystems
- A Summary of the SARS-CoV-2 Vaccines and Technologies Available or under Development
- (2021) Zainalabideen A. Abdulla et al. Pathogens
- GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2
- (2021) Ming-Shao Tsai et al. BIOMEDICINE & PHARMACOTHERAPY
- Omicron variant genome evolution and phylogenetics
- (2021) Mahmoud Kandeel et al. JOURNAL OF MEDICAL VIROLOGY
- OMICRON (B.1.1.529): A new SARS‐CoV‐2 variant of concern mounting worldwide fear
- (2021) Vikram Thakur et al. JOURNAL OF MEDICAL VIROLOGY
- Omicron variant (B.1.1.529) of SARS‐CoV‐2, a global urgent public health alert!
- (2021) Shou‐Jiang Gao et al. JOURNAL OF MEDICAL VIROLOGY
- Heavily mutated Omicron variant puts scientists on alert
- (2021) Ewen Callaway NATURE
- Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants
- (2021) Matthew McCallum et al. SCIENCE
- Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study
- (2021) Katia J Bruxvoort et al. BMJ-British Medical Journal
- Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial
- (2021) Neil Formica et al. PLOS MEDICINE
- Exploiting viral sensing mediated by Toll-like receptors to design innovative vaccines
- (2021) Rossella Sartorius et al. npj Vaccines
- Omicron variant (B.1.1.529) of SARS-CoV-2: Mutation, infectivity, transmission, and vaccine resistance
- (2021) Shi-Yan Ren et al. World Journal of Clinical Cases
- Severity, Pathogenicity and Transmissibility of Delta and Lambda Variants of SARS-CoV-2, Toxicity of Spike Protein and Possibilities for Future Prevention of COVID-19
- (2021) Mehrnoosh Moghaddar et al. Microorganisms
- PRAK-03202: A triple antigen virus-like particle vaccine candidate against SARS CoV-2
- (2021) Saumyabrata Mazumder et al. Heliyon
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
- (2020) Qun Li et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission
- (2020) Xintian Xu et al. Science China-Life Sciences
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
- (2020) Jun Lan et al. NATURE
- Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic
- (2020) Carsten Weiss et al. ACS Nano
- Pharmacological and non-pharmacological efforts at prevention, mitigation, and treatment for COVID-19
- (2020) Mohammed M. Alvi et al. JOURNAL OF DRUG TARGETING
- SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
- (2020) Giovanni Salvatori et al. Journal of Translational Medicine
- Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
- (2020) Eskild Petersen et al. LANCET INFECTIOUS DISEASES
- Construction of SARS-CoV-2 Virus-Like Particles by Mammalian Expression System
- (2020) Ruodan Xu et al. Frontiers in Bioengineering and Biotechnology
- Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
- (2020) Cheryl Keech et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development
- (2020) Subodh Kumar Samrat et al. VIRUS RESEARCH
- Biomimetic Virus-Like Particles as Severe Acute Respiratory Syndrome Coronavirus 2 Diagnostic Tools
- (2020) Soo Khim Chan et al. ACS Nano
- A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge
- (2020) Yfat Yahalom-Ronen et al. Nature Communications
- Minimal system for assembly of SARS-CoV-2 virus like particles
- (2020) Heather Swann et al. Scientific Reports
- Virus-Like Particles as an Instrument of Vaccine Production
- (2019) B. V. Syomin et al. MOLECULAR BIOLOGY
- Preparation of virus-like particle mimetic nanovesicles displaying the S protein of Middle East respiratory syndrome coronavirus using insect cells
- (2019) Tatsuya Kato et al. JOURNAL OF BIOTECHNOLOGY
- A Universal Plug-and-Display Vaccine Carrier Based on HBsAg VLP to Maximize Effective Antibody Response
- (2019) Arianna Marini et al. Frontiers in Immunology
- Induction of a high-titered antibody response using HIV gag-EV71 VP1-based virus-like particles with the capacity to protect newborn mice challenged with a lethal dose of enterovirus 71
- (2018) Xi Wang et al. ARCHIVES OF VIROLOGY
- Zika Virus Baculovirus-Expressed Virus-Like Particles Induce Neutralizing Antibodies in Mice
- (2018) Shiyu Dai et al. VIROLOGICA SINICA
- A novel synthetic trivalent single chain variable fragment (tri-scFv) construction platform based on the SpyTag/SpyCatcher protein ligase system
- (2018) Md. Kausar Alam et al. BMC BIOTECHNOLOGY
- Influenza virus-like particles composed of conserved influenza proteins and GPI-anchored CCL28/GM-CSF fusion proteins enhance protective immunity against homologous and heterologous viruses
- (2018) Jing Liu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- B Cell–Intrinsic MyD88 Signaling Promotes Initial Cell Proliferation and Differentiation To Enhance the Germinal Center Response to a Virus-like Particle
- (2017) Meijie Tian et al. JOURNAL OF IMMUNOLOGY
- Glycan shield and fusion activation of a deltacoronavirus spike glycoprotein fine-tuned for enteric infections
- (2017) Xiaoli Xiong et al. JOURNAL OF VIROLOGY
- Production of virus-like particles for vaccines
- (2017) J. Fuenmayor et al. New Biotechnology
- Major findings and recent advances in virus–like particle (VLP)-based vaccines
- (2017) Mona O. Mohsen et al. SEMINARS IN IMMUNOLOGY
- The Effective Reproduction Number of Pandemic Influenza
- (2010) Benjamin J. Cowling et al. EPIDEMIOLOGY
- Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice
- (2010) Baojing Lu et al. IMMUNOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started